17-13017793-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018127.7(ELAC2):c.155C>A(p.Ser52Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000412 in 1,455,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S52C) has been classified as Likely benign.
Frequency
Consequence
NM_018127.7 missense
Scores
Clinical Significance
Conservation
Publications
- combined oxidative phosphorylation defect type 17Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018127.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ELAC2 | NM_018127.7 | MANE Select | c.155C>A | p.Ser52Tyr | missense | Exon 1 of 24 | NP_060597.4 | ||
| ELAC2 | NM_173717.2 | c.155C>A | p.Ser52Tyr | missense | Exon 1 of 24 | NP_776065.1 | |||
| ELAC2 | NM_001165962.2 | c.155C>A | p.Ser52Tyr | missense | Exon 1 of 23 | NP_001159434.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ELAC2 | ENST00000338034.9 | TSL:1 MANE Select | c.155C>A | p.Ser52Tyr | missense | Exon 1 of 24 | ENSP00000337445.4 | ||
| ELAC2 | ENST00000395962.6 | TSL:2 | c.155C>A | p.Ser52Tyr | missense | Exon 1 of 24 | ENSP00000379291.1 | ||
| ELAC2 | ENST00000426905.7 | TSL:2 | c.155C>A | p.Ser52Tyr | missense | Exon 1 of 23 | ENSP00000405223.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000894 AC: 2AN: 223824 AF XY: 0.0000162 show subpopulations
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1455610Hom.: 0 Cov.: 31 AF XY: 0.00000553 AC XY: 4AN XY: 723740 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 17 Uncertain:1
This sequence change replaces serine, which is neutral and polar, with tyrosine, which is neutral and polar, at codon 52 of the ELAC2 protein (p.Ser52Tyr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ELAC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1424760). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at